Research ArticleClinical Investigations
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Kee H. Wong, Rafal Panek, Liam Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Chris Nutting, Wim J.G. Oyen, Kevin Harrington and Kate L. Newbold
Journal of Nuclear Medicine December 2016, 57 (12) 1843-1850; DOI: https://doi.org/10.2967/jnumed.116.174433
Kee H. Wong
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Rafal Panek
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Liam Welsh
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Dualta Mcquaid
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Alex Dunlop
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Angela Riddell
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Iain Murray
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Yong Du
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Sue Chua
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Dow-Mu Koh
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Shreerang Bhide
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Chris Nutting
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
Wim J.G. Oyen
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Kevin Harrington
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and
2The Institute of Cancer Research, Sutton and London, United Kingdom
Kate L. Newbold
1The Royal Marsden NHS Foundation Trust, Sutton and London, United Kingdom; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 12
December 1, 2016
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Kee H. Wong, Rafal Panek, Liam Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Chris Nutting, Wim J.G. Oyen, Kevin Harrington, Kate L. Newbold
Journal of Nuclear Medicine Dec 2016, 57 (12) 1843-1850; DOI: 10.2967/jnumed.116.174433
The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Kee H. Wong, Rafal Panek, Liam Welsh, Dualta Mcquaid, Alex Dunlop, Angela Riddell, Iain Murray, Yong Du, Sue Chua, Dow-Mu Koh, Shreerang Bhide, Chris Nutting, Wim J.G. Oyen, Kevin Harrington, Kate L. Newbold
Journal of Nuclear Medicine Dec 2016, 57 (12) 1843-1850; DOI: 10.2967/jnumed.116.174433
Jump to section
Related Articles
Cited By...
- Diffusion-Weighted Imaging to Assess HPV-Positive versus HPV-Negative Oropharyngeal Squamous Cell Carcinoma: The Importance of b-Values
- Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
- Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer